Richard Pazdur, M.D.
Director, Oncology Center of Excellence
Acting Director, Office of Hematology and Oncology Products
United States Food and Drug Administration
Richard Pazdur, M.D., is director of the FDA Oncology Center of Excellence, which leverages the combined skills of FDA’s scientists and reviewers with expertise in drugs, biologics, and devices to expedite the development of novel cancer products. He also serves as Acting Director, Office of Hematology and Oncology Products, in the FDA Center for Drug Evaluation and Research.
Prior to joining FDA in 1999, Dr. Pazdur was professor of medicine at The University of Texas M.D. Anderson Cancer Center. From 1982 to 1988, he served on the faculty of Wayne State University. He received his bachelor’s degree from Northwestern University, his M.D. from Loyola Stritch School of Medicine, and completed clinical training at Rush-Presbyterian St. Luke’s Medical Center and University of Chicago Hospitals and Clinics.
Dr. Pazdur has published more than 600 articles, book chapters, and abstracts, and received many awards, including recognition in Fortune magazine’s 2015 list of “50 World’s Greatest Leaders,” the Massachusetts General Hospital Cancer Center’s “The One Hundred” list in 2016, and one of “The Bloomberg 50” in 2017.